Comparison of the In Vitro Susceptibility of Ceftolozane-Tazobactam With the Cumulative Susceptibility Rates of Standard Antibiotic Combinations When Tested Against Pseudomonas aeruginosa From ICU Patients With Bloodstream Infections or Pneumonia

BACKGROUND: Pseudomonas aeruginosa remains an important cause of hospital-acquired infections in the United States and is frequently multidrug-resistant (MDR). The Infectious Diseases Society of America guidelines recommend empiric combination therapy that includes an antipseudomonal β-lactam with a...

Descripción completa

Detalles Bibliográficos
Autores principales: Shortridge, Dee, Pfaller, Michael A, Arends, S J Ryan, Raddatz, Janet, DePestel, Daryl D, Flamm, Robert K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590981/
https://www.ncbi.nlm.nih.gov/pubmed/31263733
http://dx.doi.org/10.1093/ofid/ofz240

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590981/
https://www.ncbi.nlm.nih.gov/pubmed/31263733
http://dx.doi.org/10.1093/ofid/ofz240

Ejemplares similares